# Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions

Study · id `cardio:ct-nct01092416` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01092416](<https://clinicaltrials.gov/study/NCT01092416>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01092416

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 443 participants.

## Technical summary

Registry record NCT01092416. Allocation not applicable; no masking; primary purpose treatment. Start 2010-05 (registry gives no type); primary completion 2013-01 (actual). Results posted on 2016-01-06.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 443 participants (enrolled count; ClinicalTrials.gov record NCT01092416, source copy `cardio:ctgov-nct01092416-2023-07-18`, retrieved 2026-10-26)
- Start date: 2010-05 (registry gives no type) (ClinicalTrials.gov record NCT01092416, source copy `cardio:ctgov-nct01092416-2023-07-18`, retrieved 2026-10-26)
- Primary completion: 2013-01 (actual) (ClinicalTrials.gov record NCT01092416, source copy `cardio:ctgov-nct01092416-2023-07-18`, retrieved 2026-10-26)
- Completion: 2016-01 (actual) (ClinicalTrials.gov record NCT01092416, source copy `cardio:ctgov-nct01092416-2023-07-18`, retrieved 2026-10-26)
- Results first posted: 2016-01-06 (ClinicalTrials.gov record NCT01092416, source copy `cardio:ctgov-nct01092416-2023-07-18`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT01092416, source copy `cardio:ctgov-nct01092416-2023-07-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01092416-2023-07-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions
- Acronym: ORBIT II
- Condition: Coronary Artery Disease
- Intervention (Device): Diamondback 360 Orbital Atherectomy System
- Lead sponsor: Abbott Medical Devices
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Abbott (`cardio:abbott`)

### Other papers using this trial's data

- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: ORBIT II sub-analysis: Impact of impaired renal function following treatment of severely calcified coronary lesions with the Orbital Atherectomy System (`cardio:pubmed-27567020`)
- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: Outcomes After Orbital Atherectomy of Severely Calcified Left Main Lesions: Analysis of the ORBIT II Study (`cardio:pubmed-26984932`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: f5da9cdc0097915e28f6d71ebd5175acc905cb1bd3747eed847bf6e338c62581
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
